Search

Your search keyword '"Lantelme, P"' showing total 111 results

Search Constraints

Start Over You searched for: Author "Lantelme, P" Remove constraint Author: "Lantelme, P" Publication Type Magazines Remove constraint Publication Type: Magazines
111 results on '"Lantelme, P"'

Search Results

1. Enhanced Cycle Life and Expanded Voltage Window in Aqueous Proton Full Cells Using TiO2Negative Electrodes with Cationic Vacancies

2. Patient-Level Pooled Analysis of Endovascular Ultrasound Renal Denervation or a Sham Procedure 6 Months After Medication Escalation: The RADIANCE Clinical Trial Program

3. Diversity of group 1 innate lymphoid cells in human tissues

4. Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial

10. La myocardite : une toxicité rare mais grave sous immunothérapie

11. Six-Month Results of Treatment-Blinded Medication Titration for Hypertension Control After Randomization to Endovascular Ultrasound Renal Denervation or a Sham Procedure in the RADIANCE-HTN SOLO Trial

13. Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vsaspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

14. Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial

15. Plasma NT-proBNP mirrors the deleterious cardiovascular and renal continuum in hypertension

16. Aldosterone-Producing Adenoma With a Somatic KCNJ5Mutation Revealing APC-Dependent Familial Adenomatous Polyposis

17. Adherence to Antihypertensive Treatment and the Blood Pressure–Lowering Effects of Renal Denervation in the Renal Denervation for Hypertension (DENERHTN) Trial

20. HTA résistante et barostimulation carotidienne

21. Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial

24. Decreased plasma prorenin levels in primary aldosteronism

25. R wave in aVL lead

26. Are Triplicate Urine Samples Necessary to Assess Albuminuria?

28. Molten Salts and Isotope Separation

29. The IDEAL Study : Towards Personalized Drug Treatment of Hypertension

30. European Society of Hypertension scientific newsletter

31. Niobium and titanium electrowinning in fused salts

32. Effect of abdominal aortic grafts on aortic stiffness and central hemodynamics

33. A rapid flow cytometry test based on histone H2AX phosphorylation for the sensitive and specific diagnosis of ataxia telangiectasia

34. Formation of Ni-Zr Alloys in Molten Fluorides

36. Significance of urinary angiotensinogen in essential hypertension as a function of plasma renin and aldosterone status

39. Intranodal injection of semimature monocyte-derived dendritic cells induces T helper type 1 responses to protein neoantigen

41. Spontaneous baroreflex sensitivity toward an ideal index of cardiovascular risk in hypertension?

42. Human CD8 co-receptor is strictly involved in MHC-peptide tetramer-TCR binding and T cell activation.

43. Diverse expansion potential and heterogeneous avidity in tumor-associated antigen-specific T lymphocytes from primary melanoma patients

45. Increased frequency of RAG-expressing, CD4<SUP>+</SUP>CD3<SUP>low</SUP> peripheral T lymphocytes in patients with defective responses to DNA damage

46. Difference between office and ambulatory blood pressure or real white coat effect

50. Niobium plating processes in alkali chloride melts

Catalog

Books, media, physical & digital resources